Table of Content


Introduction
Sickle Cell Disease - Overview
Sickle Cell Disease - Therapeutics Development
Sickle Cell Disease - Therapeutics Assessment
Sickle Cell Disease - Companies Involved in Therapeutics Development
Sickle Cell Disease - Drug Profiles
Sickle Cell Disease - Dormant Projects
Sickle Cell Disease - Discontinued Products
Sickle Cell Disease - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Sickle Cell Disease, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Sickle Cell Disease, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Sickle Cell Disease - Pipeline by Agios Pharmaceuticals Inc, H2 2020
Sickle Cell Disease - Pipeline by Alkermes Plc, H2 2020
Sickle Cell Disease - Pipeline by Angiocrine Bioscience Inc, H2 2020
Sickle Cell Disease - Pipeline by Annexin Pharmaceuticals AB, H2 2020
Sickle Cell Disease - Pipeline by Aruvant Sciences Inc, H2 2020
Sickle Cell Disease - Pipeline by Axcella Health Inc, H2 2020
Sickle Cell Disease - Pipeline by Beam Therapeutics Inc, H2 2020
Sickle Cell Disease - Pipeline by bluebird bio Inc, H2 2020
Sickle Cell Disease - Pipeline by Bristol-Myers Squibb Co, H2 2020
Sickle Cell Disease - Pipeline by C4X Discovery Holdings Plc, H2 2020
Sickle Cell Disease - Pipeline by Cannabis Science Inc, H2 2020
Sickle Cell Disease - Pipeline by Cell Source Inc, H2 2020
Sickle Cell Disease - Pipeline by Cetya Therapeutics Inc, H2 2020
Sickle Cell Disease - Pipeline by CRISPR Therapeutics AG, H2 2020
Sickle Cell Disease - Pipeline by CSL Ltd, H2 2020
Sickle Cell Disease - Pipeline by Daiichi Sankyo Co Ltd, H2 2020
Sickle Cell Disease - Pipeline by Editas Medicine Inc, H2 2020
Sickle Cell Disease - Pipeline by Emmaus Life Sciences Inc, H2 2020
Sickle Cell Disease - Pipeline by Epidestiny Inc, H2 2020
Sickle Cell Disease - Dormant Projects, H2 2020
Sickle Cell Disease - Discontinued Products, H2 2020